The aim of the present work was to develop a minimally invasive system for the delivery of macromolecular drugs to the deep skin tissues, so called in-skin electroporation (IN-SKIN EP), using a microneedle (MN) electrode array.
Introduction
The transdermal drug delivery system (TDDS) is a promising drug formulation that can not only be easily applied without the aid of medical staff compared to injectable formulations, but also offers several advantages, including the elimination of hepatic first-pass metabolism and severe adverse effects on the gastrointestinal tract of oral dosage forms (Jonathan Hadgraft, 1996; Asbill and Michniak, 2000) ; however, the stratum corneum, the primary barrier to the percutaneous absorption of drugs, has a key function against drug entry into the skin and the systemic circulation of TDDS.
In order to overcome the formidable barrier of the stratum corneum, several physical means have been evaluated in addition to chemical enhancers to promote the skin permeation of drugs. Among the physical means, a microneedle (MN) array can be an effective TDDS due to its advantage of providing a high-performance means to deliver therapeutic drugs through the skin barrier without causing marked skin damage (Kaushik et al., 2001; McAllister et al., 2003) . MN arrays can be made of polymers, metal, silicone rubber, polysaccharides and so on, and create new pores in the stratum corneum barrier to increase the permeation pathways of several drugs, including macromolecular drugs (Lin et al., 2001; Matriano et al., 2002; Martanto et al., 2004; Al-Qallaf and Das, 2009; Badran et al., 4 2009; Ding et al., 2009; Hafeli et al., 2009; Li et al., 2009) ; however, such new pathways do not always result in marked skin permeation. We then combined the MN array with iontophoresis (MN-IP), which can be used to increase water flow, because electroosmosis takes place through the skin from the anode to the cathode in the iontophoresis system (Wu et al., 2007) . Electroosmosis may be used like a pump syringe for conventional injection (injection system consisting of a needle and pump syringe).
Recently, another physical means, electroporation (EP), has been broadly applied to enhance the skin permeation of drugs. EP involves the creation of tiny and transient aqueous pathways in the transcellular lipid region in the stratum corneum barrier. EP application with a high-voltage electric pulse for a short period (millisecond order) results in the enhanced permeation of high molecular compounds (molecular weight of several hundreds to kilodaltons) through the skin (Medi and Singh, 2003; Fang et al., 2006; Tokumoto et al., 2006; Wong et al., 2006; Marra et al., 2008; Gowrishankar et al., 2009; Sammeta et al., 2009; Xu et al., 2009 ).
For both MN and EP, in spite of their different mechanisms, enhancement of the skin permeability of drugs is a result of the creation of new permeation pathways in the stratum corneum; however, the pathways do not always persist, so that the skin barrier function is recovered immediately after the pathways close up. TEWL (transepidermal water loss), as an index of permeability (Zhou et al., 2010) , increases after the application of MN or EP and then decreases with time, which explains the recovery of skin barrier function. To prolong the duration of new pathway (pore) openings, longer microneedles were investigated (Zhou et al., 2010) and electrolytes, such as calcium salt, were applied during EP application (Tokudome and Sugibayashi, 2004) for MN and EP studies, respectively. To achieve a longer duration of pore opening for higher drug permeation in the present study, the mutual synergic action of MN and EP was considered to further increase skin permeation and the bioavailability of macromolecules. The new present combination of MN and EP, so-called in-skin electroporation (IN-SKIN EP), was developed to combine the advantages of MN and EP. An electrically active MN array was created as a device for the present IN-SKIN EP method. Each MN could serve as a microelectrode for EP, which forms an electric field inside the skin barrier. After IN-SKIN EP application, the drug is administered to the skin surface to be delivered into deeper skin tissues. This system is different from conventional EP (ON-SKIN EP), where electrodes are applied just to the skin surface.
IN-SKIN EP may facilitate the delivery of high molecular and hydrophilic compounds to deep skin tissues. Furthermore, it affects only a small region of skin, not a wide area of skin by the MN electrode array; thus, IN-SKIN EP probably increases skin permeability but with low skin irritation.
In the present study, MN puncture of the skin was observed by scanning electron microscopy and confocal laser scanning microscopy. Fluorescein isothiocyanate (FITC)-dextran (FD-4: average molecular weight, 4.3 kDa), which has poor skin permeation due to its high molecular weight and high hydrophilicity, was selected because it could be simply analyzed by a fluorescence spectrophotometer and morphologically observed by a confocal laser fluorescence microscope. The hairless rats were anesthetized by peritoneal injection of sodium pentobarbital (50 mg/kg) and hair on the abdomen was carefully shaved using an electric clipper. Abdominal full-thickness skin was excised and adhering fat and connective tissues were carefully eliminated with a ring-ended forceps. The excised skin was confirmed to have no damage, and was immediately used for the experiment.
Application of IN-SKIN EP using an MN electrode-array
The MN electrode-array for IN-SKIN EP, shown in Fig. 1 , was prepared by modification of our previous method (Wu et al., 2007) . It was assembled using 9 acupuncture needles (Haruhari, 1.5 mm; Taiho Medical Products Co., Ltd., Hiroshima, Japan), a silicone sheet (15 × 15 ×0.8 mm; Togawa Rubber Co., Ltd., Tokushima, This obtuse tip needle array was used to apply EP at various points on the skin surface for ON-SKIN EP, so that a similar electric field could be created as a control experiment to research the IN-SKIN EP. 
In vitro skin permeation experiments
The FD-4 skin permeation experiment was performed after pretreatment of 
Scanning electron micrographic observation
Scanning electron microscopy (SEM, S-3000N; Hitachi, Tokyo, Japan) was used to observe the skin surface treated by IN-SKIN EP. A skin specimen was mounted on an aluminum stub using double-sided adhesive tape and covered with gold using an ion sputter (E-1010; Hitachi), with the stratum corneum facing up.
The samples were observed at 15 kV accelerating voltage, an approximately 20 mm working distance under a 30 Pa vacuum for skin samples.
Fluorescence confocal microscopic observation
Fluorescence confocal laser scanning was also performed for the excised hairless rat abdominal skin. After the skin permeation experiment, the skin was taken from the diffusion cell and placed in a glass-bottomed dish (Iwaki; Asahi Glass
Corp., Funabashi, Chiba, Japan), with the stratum corneum facing down, and FD-4 distribution in the skin was observed using a fluorescence confocal laser scanning microscope (CSM, Fluoview FV1000; Olympus Corp.). Fluorescence from the sample was excited by a 473 nm Hg laser (Rujirat Santipanichwong, 2009 ). Images were collected using FluoView software (ver. 1.5; Olympus Corp.).
Confocal microscopic observation
In order to measure the actual depth of pores made by MN alone or IN-SKIN EP, the interior of the skin was observed using a confocal laser scanning microscope (CLS, Vivascope1500, wavelength: 830 nm; Rochester, NY, USA).
This instrument can be used to non-invasively observe the interior of tissues. Tissue morphology up to a depth of 350 µm can be observed optically, with high sensitivity and specificity, correlating with histological sectioning (Altintas et al., 2008; Altintas et al., 2009 ). The punctured areas of excised abdominal skin of hairless rats were observed immediately after puncture with MN alone or IN-SKIN EP.
Measurement of lactate dehydrogenase (LDH) leakage from pretreated skin in vivo
Hairless rats were anesthetized by s.c. injection of urethane (1.0 mg/kg), and hair on the abdomen was carefully removed using an electric clipper. A glass cell cap was attached using adhesive (Aronalpha; Toagosei, Tokyo, Japan) after pretreatment with IN-SKIN EP. Earle's balanced salt solution (EBSS, 2.0 mL) was then added to the glass cell cap. Whole solution was periodically collected from the glass cap cell, and the same volume of blank EBSS was added to keep the volume constant. LDH leached from the stratum corneum side was determined by an assay kit (Lactate Dehydrogenase Cytotoxicity Assay Kit; Cayman, MI, USA).
Non-pretreated intact skin and stripped skin were also investigated for comparison.
The stripped skin was made by stripping the stratum corneum 20 times with tape.
All experiments were carried out in vivo.
8. Statistical analysis
Statistical analysis was performed using the unpaired Student's t-test.
Significant difference was accepted at 0.05. ANOVA was also applied in this study (Tokumoto et al., 2005) . observed to assess the effect of IN-SKIN EP to produce a transport channel across the primary barrier, the stratum corneum, against drug entry to viable tissues. The diameter of the newly produced transport channels was measured horizontally and vertically, and their average size was used as an index of channel size. The average diameter of the channel produced by MN alone was 77.65 μm (Fig. 3b) , and that by ON-SKIN EP was 168.83 μm (Fig. 3c ), but no distinct channel was produced by ON-SKIN EP. The average diameter of the channel with IN-SKIN EP pretreatment was 166.20 μm (Fig. 3d) . IN-SKIN EP produced the largest and deepest pore channels in skin, among the methods in the present study, and these channels would be new effective permeation pathways for chemical compounds, even macromolecules. (Fig. 2) . Correspondingly, in Fig. 4a , the average depth of fluorescent part is 20-30 μm, so it can be considered that FD-4 is only distributed on the skin and in the stratum corneum but not permeating to the deep part. In the skin pretreated with MN (Fig. 4b) , the arrow shows puncture site by MN, where the fluorescence front was about 60 μm depth. In ON-SKIN EP (EP condition: 200 V, 10 ms, 10 pulses) (Fig. 4c) , the fluorescence was distributed averagely deeper than intact skin or MN pretreatment. The thickness of green fluorescence in Fig. 4a-c was well correlated to the skin permeation of FD-4 as shown in Fig. 2 . Although only a little difference was found among the picture in Fig. 4a-c (Fig. 5f ). The pore could still be observed in the recorded depth. These data show a coincidence in depth with Fig.   4b and d. In addition, the zone of the puncture periphery, which was a circular region of approximately 100-μm diameter, was dark in the images. This could be considered a type of change in skin tissues, such as localized transport regions (LTR), as well as the Joule heat effect. Although evidence of the creation of these LTRs is still indirect in the present study, this zone is also considered as the effect of EP and acts as an important part of drug permeation (Pliquett et al., 1996; Prausnitz, 1996; Zewert et al., 1999; Denet et al., 2004) . Figure 6 shows the effect of the application voltage and pulse width of EP on the cumulative amounts of FD-4 that permeated skin pretreated by IN-SKIN EP (over 8 h). Voltage, pulse width and the number of pulses are the three most important parameters of the EP effect on skin permeation (Sharma et al., 1999) . In this study, the effective application period of IN-SKIN EP was fixed to 10 s, and the square wave pulse was applied at 1 pulse/s, so the number of pulses became 10. 
Results and discussion

Effect of IN-SKIN EP pretreatment on the skin permeation of FD-4
2. Effect of voltage and pulse width on IN-SKIN EP treatment
Influence of IN-SKIN EP on lactate dehydrogenase (LDH) leaching from skin
EP application was found to increase tissue temperature due to Joule heating (Becker and Kuznetsov, 2007) . It was considered from the present SEM images that a certain level of scorching was found in pores punctured by IN-SKIN EP.
Cutaneous cells may be damaged when the skin is punctured by IN-SKIN EP. In order to estimate the irritation caused by IN-SKIN EP, LDH leaching from the skin was determined. The LDH leaching was used to assess skin viability (Messager et al., 2003; Wu et al., 2006) in order to evaluate the safety of different physical enhancing methods. Two strong EP conditions (200 V, 10 ms, 10 pulses and 100 V, 100 ms, 10 pulses) were evaluated. Stripped skin was also evaluated for comparison. Figure 7 shows the cumulative amount of LDH leakage from the skin surface over 1, 4 and 8 h after pretreatment. The cumulative amount of LDH leaching from stripped skin was 6.6 times that of intact skin over 8 h. In contrast, no significant difference was found between intact skin and either of the pretreatment conditions; therefore, in the present study, it can be concluded that IN-SKIN EP could create a novel permeation route to enhance penetration with little damage to skin cells.
Histological investigation is necessary to evaluate the safety of the IN-SKIN EP method in detail. 
Conclusions
In order to deliver macromolecules through skin, it is important to surmount the stratum corneum barrier to increase permeability. To address this challenge, a In the present study, the low irritation of IN-SKIN EP could be concluded from the LDH experiment.
In conclusion, IN-SKIN EP can effectively deliver high molecular and hydrophilic drugs. Not only drug solutions but also the topical formulations, such as gel, ointment or a patch can be applied after pretreatment with IN-SKIN EP, and could be more convenient for clinical application. Each data point represents the mean ± S.E. of four or five experiments. 
Figure legends
